Observational cohort study of rilpivirine (RPV) utilization in Europe

INTRODUCTION: Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. METHODS: Participants of EuroSIDA were included if they had started a RPV- or an EFV-containing regimen over November 2011-December 2017....

Descripción completa

Detalles Bibliográficos
Autores principales: Cozzi-Lepri, Alessandro, Peters, Lars, Pelchen-Matthews, Annegret, Neesgaard, Bastian, De Wit, Stephane, Johansen, Isik Somuncu, Edwards, Simon, Stephan, Christoph, Adamis, Georgios, Staub, Therese, Zagalo, Alexandra, Domingo, Pere, Elbirt, Daniel, Kusejko, Katharina, Brännström, Johanna, Paduta, Dzmitry, Trofimova, Tatyana, Szlavik, Janos, Zilmer, Kai, Losso, Marcello, Van Eygen, Veerle, Pai, Helen, Lundgren, Jens, Mocroft, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357334/
https://www.ncbi.nlm.nih.gov/pubmed/35933352
http://dx.doi.org/10.1186/s12981-022-00457-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357334/
https://www.ncbi.nlm.nih.gov/pubmed/35933352
http://dx.doi.org/10.1186/s12981-022-00457-0

Ejemplares similares